ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NUVL Nuvalent Inc

69.07
-1.28 (-1.82%)
Last Updated: 11:18:08
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Nuvalent Inc NUVL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-1.28 -1.82% 69.07 11:18:08
Open Price Low Price High Price Close Price Previous Close
69.99 69.07 70.69 70.35
more quote information »

Recent News

Date Time Source Heading
4/08/202415:30PRNUSNuvalent Presents New Preclinical Data Supporting Profiles..
3/05/202415:52PRNUSNuvalent to Present New Preclinical Data on HER2-Selective..
2/27/202406:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/27/202405:42EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202405:38EDGAR2Form 8-K - Current report
2/27/202405:30PRNUSNuvalent Highlights Pipeline Progress, Reiterates Key..
2/27/202405:15PRNUSNuvalent Receives U.S. FDA Breakthrough Therapy Designation..
2/12/202405:30PRNUSNuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical..
2/01/202405:30PRNUSNuvalent to Participate in the Guggenheim Healthcare Talks..
1/09/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:40EDGAR2Form 8-K - Current report
1/08/202405:30PRNUSNuvalent Announces "OnTarget 2026" Operating Plan and Key..
12/28/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202315:31EDGAR2Form 144 - Report of proposed sale of securities
12/21/202305:30PRNUSNuvalent to Present at the 42nd Annual J.P. Morgan..
12/20/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202317:00EDGAR2Form 144 - Report of proposed sale of securities
12/18/202316:45EDGAR2Form 144 - Report of proposed sale of securities
12/18/202316:32EDGAR2Form 144 - Report of proposed sale of securities
12/18/202316:23EDGAR2Form 144 - Report of proposed sale of securities
11/30/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202305:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202305:45EDGAR2Form 8-K - Current report
11/14/202305:30PRNUSNuvalent Highlights Corporate and Pipeline Achievements and..
11/03/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202305:30PRNUSNuvalent to Participate in the BMO Virtual BioPharma..
10/26/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202317:01EDGAR2Form 144 - Report of proposed sale of securities
10/17/202315:07EDGAR2Form 8-K - Current report
10/17/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/16/202320:55PRNUSNuvalent Announces Pricing of Public Offering of Common..
10/16/202306:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/16/202306:30PRNUSNuvalent Announces Public Offering of Common Stock
10/13/202305:40EDGAR2Form 8-K - Current report
10/13/202305:30PRNUSNuvalent Reports Preliminary Phase 1 Clinical Data from..
10/06/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/06/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202315:12EDGAR2Form 144 - Report of proposed sale of securities
10/04/202315:05EDGAR2Form 8-K - Current report
10/04/202311:21PRNUSPreliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial..
9/19/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202305:30PRNUSNuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2..
9/06/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock